Myeloid-derived suppressor cells: Cellular missiles to target tumors

Dinesh Chandra, Claudia Gravekamp

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

While conventional anticancer therapies, including surgical resection, radiotherapy, and/or chemotherapy, are relatively efficient at eliminating primary tumors, these treatment modalities are largely ineffective against metastases. At least in part, this reflects the rather inefficient delivery of conventional anticancer agents to metastatic lesions. We have recently demonstrated that myeloid-derived suppressor cells (MDSCs) can be used as cellular missiles to selectively deliver a radioisotope-coupled attenuated variant of Listeria monocytogenes to both primary and metastatic neoplastic lesions in mice with pancreatic cancer. This novel immunotherapeutic intervention robustly inhibited tumor growth while promoting a dramatic decrease in the number of metastases.

Original languageEnglish (US)
Article numbere26967
JournalOncoImmunology
Volume2
Issue number11
DOIs
StatePublished - 2013

Fingerprint

Neoplasm Metastasis
Listeria monocytogenes
Pancreatic Neoplasms
Radioisotopes
Antineoplastic Agents
Neoplasms
Radiotherapy
Drug Therapy
Therapeutics
Growth
Myeloid-Derived Suppressor Cells

Keywords

  • Cancer vaccine
  • Listeria
  • MDSC
  • Targeted therapy
  • Tumor microenvironment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Oncology
  • Immunology

Cite this

Myeloid-derived suppressor cells : Cellular missiles to target tumors. / Chandra, Dinesh; Gravekamp, Claudia.

In: OncoImmunology, Vol. 2, No. 11, e26967, 2013.

Research output: Contribution to journalArticle

@article{5ad9a2d41edf4d1980a72a3a65fe74e4,
title = "Myeloid-derived suppressor cells: Cellular missiles to target tumors",
abstract = "While conventional anticancer therapies, including surgical resection, radiotherapy, and/or chemotherapy, are relatively efficient at eliminating primary tumors, these treatment modalities are largely ineffective against metastases. At least in part, this reflects the rather inefficient delivery of conventional anticancer agents to metastatic lesions. We have recently demonstrated that myeloid-derived suppressor cells (MDSCs) can be used as cellular missiles to selectively deliver a radioisotope-coupled attenuated variant of Listeria monocytogenes to both primary and metastatic neoplastic lesions in mice with pancreatic cancer. This novel immunotherapeutic intervention robustly inhibited tumor growth while promoting a dramatic decrease in the number of metastases.",
keywords = "Cancer vaccine, Listeria, MDSC, Targeted therapy, Tumor microenvironment",
author = "Dinesh Chandra and Claudia Gravekamp",
year = "2013",
doi = "10.4161/onci.26967",
language = "English (US)",
volume = "2",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Landes Bioscience",
number = "11",

}

TY - JOUR

T1 - Myeloid-derived suppressor cells

T2 - Cellular missiles to target tumors

AU - Chandra, Dinesh

AU - Gravekamp, Claudia

PY - 2013

Y1 - 2013

N2 - While conventional anticancer therapies, including surgical resection, radiotherapy, and/or chemotherapy, are relatively efficient at eliminating primary tumors, these treatment modalities are largely ineffective against metastases. At least in part, this reflects the rather inefficient delivery of conventional anticancer agents to metastatic lesions. We have recently demonstrated that myeloid-derived suppressor cells (MDSCs) can be used as cellular missiles to selectively deliver a radioisotope-coupled attenuated variant of Listeria monocytogenes to both primary and metastatic neoplastic lesions in mice with pancreatic cancer. This novel immunotherapeutic intervention robustly inhibited tumor growth while promoting a dramatic decrease in the number of metastases.

AB - While conventional anticancer therapies, including surgical resection, radiotherapy, and/or chemotherapy, are relatively efficient at eliminating primary tumors, these treatment modalities are largely ineffective against metastases. At least in part, this reflects the rather inefficient delivery of conventional anticancer agents to metastatic lesions. We have recently demonstrated that myeloid-derived suppressor cells (MDSCs) can be used as cellular missiles to selectively deliver a radioisotope-coupled attenuated variant of Listeria monocytogenes to both primary and metastatic neoplastic lesions in mice with pancreatic cancer. This novel immunotherapeutic intervention robustly inhibited tumor growth while promoting a dramatic decrease in the number of metastases.

KW - Cancer vaccine

KW - Listeria

KW - MDSC

KW - Targeted therapy

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=84892400370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892400370&partnerID=8YFLogxK

U2 - 10.4161/onci.26967

DO - 10.4161/onci.26967

M3 - Article

AN - SCOPUS:84892400370

VL - 2

JO - OncoImmunology

JF - OncoImmunology

SN - 2162-4011

IS - 11

M1 - e26967

ER -